1019 | -0.2632 | 10.67 | -3.877 | 0.0001301 | 0.0006885 | -0.07041 | 1019 | CDK4 | cyclin-dependent kinase 4 | ENSG00000135446 | 123829, 609048 |
10399 | 0.4825 | 6.832 | 5.048 | 7.812e-07 | 5.863e-06 | 4.817 | 10399 | GNB2L1 | guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1 | ENSG00000204628 | 176981 |
11221 | 2.424 | 6.059 | 11.27 | 9.433e-25 | 4.471e-23 | 45.39 | 11221 | DUSP10 | dual specificity phosphatase 10 | ENSG00000143507 | 608867 |
11261 | 0.4645 | 11.58 | 7.46 | 9.592e-13 | 1.476e-11 | 18.09 | 11261 | CHP | calcium binding protein P22 | ENSG00000187446 | 606988 |
1386 | -0.5172 | 7.487 | -3.881 | 0.0001283 | 0.0006793 | -0.05683 | 1386 | ATF2 | activating transcription factor 2 | ENSG00000115966 | 123811 |
1387 | -2.029 | 8.584 | -17.92 | 3.612e-49 | 1.437e-46 | 101.2 | 1387 | CREBBP | CREB binding protein | ENSG00000005339 | 180849, 600140 |
1390 | -0.5121 | 9.586 | -8.007 | 2.683e-14 | 4.819e-13 | 21.61 | 1390 | CREM | cAMP responsive element modulator | ENSG00000095794 | 123812 |
1452 | -0.1782 | 11.48 | -4.121 | 4.898e-05 | 0.0002779 | 0.8543 | 1452 | CSNK1A1 | casein kinase 1, alpha 1 | ENSG00000113712 | 600505 |
1457 | -0.6943 | 9.992 | -12.57 | 2.392e-29 | 1.718e-27 | 55.88 | 1457 | CSNK2A1 | casein kinase 2, alpha 1 polypeptide | ENSG00000101266 | 115440 |
1540 | 0.5269 | 5.545 | 6.619 | 1.694e-10 | 2.05e-09 | 13.02 | 1540 | CYLD | cylindromatosis (turban tumor syndrome) | ENSG00000083799 | 132700, 601606, 605018, 605041 |
1647 | 0.6207 | 10.15 | 5.466 | 9.763e-08 | 8.358e-07 | 6.827 | 1647 | GADD45A | growth arrest and DNA-damage-inducible, alpha | ENSG00000116717 | 126335 |
1649 | 0.3815 | 7.829 | 4.465 | 1.141e-05 | 7.207e-05 | 2.242 | 1649 | DDIT3 | DNA-damage-inducible transcript 3 | ENSG00000175197 | 126337, 613488 |
1677 | -0.8144 | 6.046 | -5.437 | 1.135e-07 | 9.617e-07 | 6.682 | 1677 | DFFB | DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase) | ENSG00000169598 | 601883 |
1843 | 1.559 | 8.384 | 6.057 | 4.202e-09 | 4.331e-08 | 9.884 | 1843 | DUSP1 | dual specificity phosphatase 1 | ENSG00000120129 | 600714 |
1959 | 0.7933 | 4.81 | 6.681 | 1.172e-10 | 1.443e-09 | 13.38 | 1959 | EGR2 | early growth response 2 | ENSG00000122877 | 129010, 145900, 605253, 607678 |
1977 | -0.4679 | 9.441 | -4.241 | 2.974e-05 | 0.0001751 | 1.329 | 1977 | EIF4E | eukaryotic translation initiation factor 4E | ENSG00000151247 | 133440 |
2033 | -0.7882 | 6.866 | -7.239 | 3.891e-12 | 5.622e-11 | 16.71 | 2033 | EP300 | E1A binding protein p300 | ENSG00000100393 | 114500, 180849, 602700, 613684 |
22926 | 0.346 | 8.14 | 5.057 | 7.457e-07 | 5.616e-06 | 4.862 | 22926 | ATF6 | activating transcription factor 6 | ENSG00000118217 | 605537 |
23043 | 1.292 | 5.939 | 10.49 | 4.085e-22 | 1.542e-20 | 39.38 | 23043 | TNIK | TRAF2 and NCK interacting kinase | ENSG00000154310 | 610005 |
23085 | 0.5979 | 6.301 | 5.642 | 3.92e-08 | 3.541e-07 | 7.712 | 23085 | ERC1 | ELKS/RAB6-interacting/CAST family member 1 | ENSG00000082805 | 607127 |
23118 | -0.4852 | 8.522 | -5.117 | 5.586e-07 | 4.287e-06 | 5.14 | 23118 | TAB2 | TGF-beta activated kinase 1/MAP3K7 binding protein 2 | ENSG00000055208 | 605101, 612863 |
2353 | 0.471 | 4.873 | 5.578 | 5.479e-08 | 4.845e-07 | 7.387 | 2353 | FOS | FBJ murine osteosarcoma viral oncogene homolog | ENSG00000170345 | 164810 |
2534 | 1.334 | 8.725 | 13.06 | 4.076e-31 | 3.466e-29 | 59.91 | 2534 | FYN | FYN oncogene related to SRC, FGR, YES | ENSG00000010810 | 137025 |
2934 | 0.7551 | 7.783 | 7.606 | 3.752e-13 | 6.005e-12 | 19.01 | 2934 | GSN | gelsolin | ENSG00000148180 | 105120, 137350 |
3164 | 0.5399 | 5.729 | 5.344 | 1.815e-07 | 1.503e-06 | 6.227 | 3164 | NR4A1 | nuclear receptor subfamily 4, group A, member 1 | ENSG00000123358 | 139139 |
317 | 0.8068 | 6.947 | 8.146 | 1.055e-14 | 1.966e-13 | 22.52 | 317 | APAF1 | apoptotic peptidase activating factor 1 | ENSG00000120868 | 602233 |
3726 | 0.9068 | 8.474 | 8.706 | 2.226e-16 | 4.919e-15 | 26.33 | 3726 | JUNB | jun B proto-oncogene | ENSG00000171223 | 165161 |
3837 | -1.098 | 10.44 | -15.37 | 1.237e-39 | 2.356e-37 | 79.38 | 3837 | KPNB1 | karyopherin (importin) beta 1 | ENSG00000108424 | 602738 |
4000 | 0.6461 | 8.965 | 6.935 | 2.541e-11 | 3.359e-10 | 14.88 | 4000 | LMNA | lamin A/C | ENSG00000160789 | 115200, 150330, 151660, 159001, 176670, 181350, 212112, 248370, 275210, 277700, 605588, 610140, 613205 |
4001 | -2.244 | 7.503 | -10.28 | 2.089e-21 | 7.362e-20 | 37.76 | 4001 | LMNB1 | lamin B1 | ENSG00000113368 | 150340, 169500 |
4067 | 0.7111 | 6.744 | 5.027 | 8.633e-07 | 6.43e-06 | 4.721 | 4067 | LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | ENSG00000254087 | 165120 |
4137 | 0.7174 | 5.28 | 8.176 | 8.615e-15 | 1.633e-13 | 22.72 | 4137 | MAPT | microtubule-associated protein tau | ENSG00000257437, ENSG00000186868 | 157140, 168600, 172700, 260540, 600274, 601104 |
4208 | 1.333 | 7.608 | 11.52 | 1.225e-25 | 6.144e-24 | 47.41 | 4208 | MEF2C | myocyte enhancer factor 2C | ENSG00000081189 | 600662, 613443 |
4215 | 0.7498 | 7.869 | 7.647 | 2.873e-13 | 4.639e-12 | 19.27 | 4215 | MAP3K3 | mitogen-activated protein kinase kinase kinase 3 | ENSG00000198909 | 602539 |
4216 | -0.9797 | 7.796 | -10.01 | 1.626e-20 | 5.203e-19 | 35.73 | 4216 | MAP3K4 | mitogen-activated protein kinase kinase kinase 4 | ENSG00000085511 | 602425 |
4286 | 1.014 | 7.089 | 11.69 | 3.194e-26 | 1.74e-24 | 48.74 | 4286 | MITF | microphthalmia-associated transcription factor | ENSG00000187098 | 103470, 103500, 156845, 193510 |
4609 | 0.3352 | 10.92 | 4.91 | 1.506e-06 | 1.083e-05 | 4.185 | 4609 | MYC | v-myc myelocytomatosis viral oncogene homolog (avian) | ENSG00000136997 | 113970, 190080 |
4616 | 0.714 | 8.351 | 4.195 | 3.613e-05 | 0.0002089 | 1.143 | 4616 | GADD45B | growth arrest and DNA-damage-inducible, beta | ENSG00000099860 | 604948 |
466 | -1.791 | 8.875 | -13.62 | 3.867e-33 | 3.988e-31 | 64.53 | 466 | ATF1 | activating transcription factor 1 | ENSG00000123268 | 123803 |
4790 | -0.6121 | 7.776 | -7.454 | 9.959e-13 | 1.527e-11 | 18.05 | 4790 | NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | ENSG00000109320 | 164011 |
4792 | -0.639 | 10.15 | -5.111 | 5.75e-07 | 4.394e-06 | 5.112 | 4792 | NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | ENSG00000100906 | 164008, 612132 |
4926 | -0.3984 | 8.116 | -3.983 | 8.581e-05 | 0.0004667 | 0.323 | 4926 | NUMA1 | nuclear mitotic apparatus protein 1 | ENSG00000137497 | 164009 |
5063 | 0.4876 | 5.652 | 4.084 | 5.701e-05 | 0.0003197 | 0.7102 | 5063 | PAK3 | p21 protein (Cdc42/Rac)-activated kinase 3 | ENSG00000077264 | 300142, 300558 |
51347 | 1.757 | 8.072 | 16.21 | 9.447e-43 | 2.287e-40 | 86.5 | 51347 | TAOK3 | TAO kinase 3 | ENSG00000135090 | NA |
5154 | -1.459 | 6.825 | -8.03 | 2.31e-14 | 4.173e-13 | 21.75 | 5154 | PDGFA | platelet-derived growth factor alpha polypeptide | ENSG00000197461 | 173430 |
5292 | 0.693 | 5.959 | 6.484 | 3.731e-10 | 4.347e-09 | 12.25 | 5292 | PIM1 | pim-1 oncogene | ENSG00000137193 | 164960 |
5566 | 0.4129 | 9.549 | 5.391 | 1.431e-07 | 1.198e-06 | 6.457 | 5566 | PRKACA | protein kinase, cAMP-dependent, catalytic, alpha | ENSG00000072062 | 601639 |
5578 | 0.9039 | 7.313 | 9.863 | 4.949e-20 | 1.508e-18 | 34.63 | 5578 | PRKCA | protein kinase C, alpha | ENSG00000154229 | 176960 |
5580 | 1.553 | 7.478 | 13.55 | 6.706e-33 | 6.759e-31 | 63.99 | 5580 | PRKCD | protein kinase C, delta | ENSG00000163932 | 176977 |
5583 | 0.7238 | 8.555 | 7.383 | 1.569e-12 | 2.362e-11 | 17.61 | 5583 | PRKCH | protein kinase C, eta | ENSG00000027075 | 601367, 605437 |
5604 | 0.2558 | 10.13 | 4.478 | 1.075e-05 | 6.812e-05 | 2.299 | 5604 | MAP2K1 | mitogen-activated protein kinase kinase 1 | ENSG00000169032 | 115150, 176872 |
5606 | 1.656 | 9.058 | 12.58 | 2.254e-29 | 1.63e-27 | 55.93 | 5606 | MAP2K3 | mitogen-activated protein kinase kinase 3 | ENSG00000034152 | 602315 |
5608 | 0.6606 | 7.955 | 5.423 | 1.215e-07 | 1.027e-06 | 6.616 | 5608 | MAP2K6 | mitogen-activated protein kinase kinase 6 | ENSG00000108984 | 601254 |
5610 | -0.6904 | 8.989 | -9.759 | 1.078e-19 | 3.194e-18 | 33.86 | 5610 | EIF2AK2 | eukaryotic translation initiation factor 2-alpha kinase 2 | ENSG00000055332 | 176871 |
56848 | -0.5139 | 6.517 | -5.282 | 2.481e-07 | 2.01e-06 | 5.925 | 56848 | SPHK2 | sphingosine kinase 2 | ENSG00000063176 | 607092 |
5770 | 1.232 | 8.308 | 10.03 | 1.431e-20 | 4.621e-19 | 35.86 | 5770 | PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | ENSG00000196396 | 125853, 176885 |
5894 | -0.6406 | 9.525 | -6.937 | 2.521e-11 | 3.339e-10 | 14.88 | 5894 | RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | ENSG00000132155 | 164760, 611553, 611554 |
5898 | 0.4758 | 9.213 | 4.1 | 5.333e-05 | 0.0003007 | 0.7736 | 5898 | RALA | v-ral simian leukemia viral oncogene homolog A (ras related) | ENSG00000006451 | 179550 |
5901 | -0.2564 | 13.01 | -5.549 | 6.372e-08 | 5.586e-07 | 7.241 | 5901 | RAN | RAN, member RAS oncogene family | ENSG00000132341 | 601179 |
595 | -0.7809 | 10.02 | -5.764 | 2.053e-08 | 1.921e-07 | 8.34 | 595 | CCND1 | cyclin D1 | ENSG00000110092 | 114500, 151400, 168461, 193300, 254500 |
596 | 0.3663 | 4.863 | 4.324 | 2.096e-05 | 0.0001267 | 1.662 | 596 | BCL2 | B-cell CLL/lymphoma 2 | ENSG00000171791 | 151430 |
598 | -0.9141 | 9.808 | -9.107 | 1.288e-17 | 3.191e-16 | 29.14 | 598 | BCL2L1 | BCL2-like 1 | ENSG00000171552 | 600039 |
6304 | 0.7952 | 7.413 | 4.979 | 1.088e-06 | 7.984e-06 | 4.498 | 6304 | SATB1 | SATB homeobox 1 | ENSG00000182568 | 602075 |
637 | -0.4952 | 7.455 | -4.136 | 4.605e-05 | 0.0002624 | 0.9128 | 637 | BID | BH3 interacting domain death agonist | ENSG00000015475 | 601997 |
6548 | 0.9585 | 8.519 | 8.857 | 7.663e-17 | 1.776e-15 | 27.38 | 6548 | SLC9A1 | solute carrier family 9 (sodium/hydrogen exchanger), member 1 | ENSG00000090020 | 107310 |
6609 | 0.3662 | 6.934 | 4.062 | 6.23e-05 | 0.0003471 | 0.6261 | 6609 | SMPD1 | sphingomyelin phosphodiesterase 1, acid lysosomal | ENSG00000166311 | 257200, 607608, 607616 |
6709 | 0.6347 | 5.217 | 5.968 | 6.847e-09 | 6.858e-08 | 9.408 | 6709 | SPTAN1 | spectrin, alpha, non-erythrocytic 1 (alpha-fodrin) | ENSG00000197694 | 182810, 613477 |
6772 | 0.5116 | 9.87 | 8.091 | 1.535e-14 | 2.824e-13 | 22.15 | 6772 | STAT1 | signal transducer and activator of transcription 1, 91kDa | ENSG00000115415 | 209950, 600555, 613796, 614162 |
6850 | -0.5123 | 5.428 | -5.027 | 8.623e-07 | 6.425e-06 | 4.722 | 6850 | SYK | spleen tyrosine kinase | ENSG00000165025 | 600085 |
6885 | 0.6395 | 7.889 | 8.39 | 2.007e-15 | 4.08e-14 | 24.16 | 6885 | MAP3K7 | mitogen-activated protein kinase kinase kinase 7 | ENSG00000135341 | 602614 |
6929 | -0.2711 | 9.7 | -4.261 | 2.736e-05 | 0.0001625 | 1.408 | 6929 | TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | ENSG00000071564 | 147141 |
7091 | 0.8033 | 6.259 | 5.468 | 9.65e-08 | 8.268e-07 | 6.839 | 7091 | TLE4 | transducin-like enhancer of split 4 (E(sp1) homolog, Drosophila) | ENSG00000106829 | 605132 |
7150 | 0.4522 | 11.13 | 6.378 | 6.877e-10 | 7.769e-09 | 11.65 | 7150 | TOP1 | topoisomerase (DNA) I | ENSG00000198900 | 126420 |
7249 | 0.3857 | 4.362 | 4.209 | 3.399e-05 | 0.0001975 | 1.201 | 7249 | TSC2 | tuberous sclerosis 2 | ENSG00000103197 | 191092, 191100, 606690 |
7323 | -0.2299 | 10.44 | -6.459 | 4.301e-10 | 4.967e-09 | 12.11 | 7323 | UBE2D3 | ubiquitin-conjugating enzyme E2D 3 | ENSG00000109332 | 602963 |
7514 | -0.7121 | 11.74 | -17.56 | 7.92e-48 | 2.846e-45 | 98.11 | 7514 | XPO1 | exportin 1 (CRM1 homolog, yeast) | ENSG00000082898 | 602559 |
7525 | 0.2859 | 11.07 | 4.396 | 1.538e-05 | 9.49e-05 | 1.957 | 7525 | YES1 | v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 | ENSG00000176105 | 164880 |
7533 | -0.7826 | 8.591 | -6.455 | 4.406e-10 | 5.08e-09 | 12.08 | 7533 | YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide | ENSG00000128245 | 113508 |
7867 | -0.2739 | 10.28 | -4.483 | 1.054e-05 | 6.693e-05 | 2.318 | 7867 | MAPKAPK3 | mitogen-activated protein kinase-activated protein kinase 3 | ENSG00000114738 | 602130 |
801 | 0.6272 | 11.46 | 7.163 | 6.238e-12 | 8.795e-11 | 16.25 | 801 | CALM1 | calmodulin 1 (phosphorylase kinase, delta) | ENSG00000143933, ENSG00000160014, ENSG00000198668 | 114180 |
8021 | -0.5882 | 7.102 | -6.255 | 1.382e-09 | 1.509e-08 | 10.97 | 8021 | NUP214 | nucleoporin 214kDa | ENSG00000126883 | 114350, 601626 |
805 | 0.1892 | 13.06 | 4.565 | 7.338e-06 | 4.775e-05 | 2.664 | 805 | CALM2 | calmodulin 2 (phosphorylase kinase, delta) | ENSG00000143933, ENSG00000160014, ENSG00000198668 | 114182 |
8061 | -1.373 | 11.23 | -12.46 | 6.221e-29 | 4.29e-27 | 54.93 | 8061 | FOSL1 | FOS-like antigen 1 | ENSG00000175592 | 136515 |
837 | -0.6216 | 7.57 | -5.225 | 3.285e-07 | 2.621e-06 | 5.653 | 837 | CASP4 | caspase 4, apoptosis-related cysteine peptidase | ENSG00000196954 | 602664 |
839 | -0.9565 | 7.782 | -8.633 | 3.716e-16 | 8.005e-15 | 25.82 | 839 | CASP6 | caspase 6, apoptosis-related cysteine peptidase | ENSG00000138794 | 601532 |
840 | -0.4384 | 7.448 | -5.14 | 4.988e-07 | 3.872e-06 | 5.25 | 840 | CASP7 | caspase 7, apoptosis-related cysteine peptidase | ENSG00000165806 | 601761 |
841 | -0.7273 | 8.641 | -7.755 | 1.428e-13 | 2.402e-12 | 19.96 | 841 | CASP8 | caspase 8, apoptosis-related cysteine peptidase | ENSG00000064012 | 114480, 114550, 211980, 601763, 607271 |
842 | 0.862 | 8.253 | 11.67 | 3.65e-26 | 1.978e-24 | 48.61 | 842 | CASP9 | caspase 9, apoptosis-related cysteine peptidase | ENSG00000132906 | 602234 |
8439 | -0.894 | 8.165 | -7.741 | 1.563e-13 | 2.618e-12 | 19.87 | 8439 | NSMAF | neutral sphingomyelinase (N-SMase) activation associated factor | ENSG00000035681 | 603043 |
84823 | -0.7156 | 8.315 | -4.439 | 1.273e-05 | 7.978e-05 | 2.137 | 84823 | LMNB2 | lamin B2 | ENSG00000176619 | 150341, 608709 |
8550 | -0.2773 | 8.466 | -4.213 | 3.349e-05 | 0.0001948 | 1.216 | 8550 | MAPKAPK5 | mitogen-activated protein kinase-activated protein kinase 5 | ENSG00000089022 | 606723 |
8567 | 0.4179 | 7.194 | 4.246 | 2.914e-05 | 0.000172 | 1.348 | 8567 | MADD | MAP-kinase activating death domain | ENSG00000110514 | 603584 |
8569 | 0.6134 | 8.539 | 8.95 | 3.959e-17 | 9.402e-16 | 28.03 | 8569 | MKNK1 | MAP kinase interacting serine/threonine kinase 1 | ENSG00000079277 | 606724 |
868 | 1.014 | 8.49 | 12.43 | 7.578e-29 | 5.162e-27 | 54.73 | 868 | CBLB | Cbl proto-oncogene, E3 ubiquitin protein ligase B | ENSG00000114423 | 604491 |
8772 | -1.194 | 10.21 | -13.18 | 1.591e-31 | 1.39e-29 | 60.85 | 8772 | FADD | Fas (TNFRSF6)-associated via death domain | ENSG00000168040 | 602457, 613759 |
8878 | 0.6187 | 5.824 | 6.784 | 6.355e-11 | 8.021e-10 | 13.98 | 8878 | SQSTM1 | sequestosome 1 | ENSG00000161011 | 601530, 602080 |
9020 | 0.736 | 6.496 | 4.888 | 1.674e-06 | 1.196e-05 | 4.082 | 9020 | MAP3K14 | mitogen-activated protein kinase kinase kinase 14 | ENSG00000006062 | 604655 |
9064 | -0.6423 | 5.886 | -7.259 | 3.427e-12 | 4.999e-11 | 16.84 | 9064 | MAP3K6 | mitogen-activated protein kinase kinase kinase 6 | ENSG00000142733 | 604468 |
9261 | 0.5797 | 9.767 | 7.27 | 3.206e-12 | 4.701e-11 | 16.9 | 9261 | MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | ENSG00000162889 | 602006 |
9448 | -0.407 | 10.18 | -5.044 | 7.961e-07 | 5.963e-06 | 4.799 | 9448 | MAP4K4 | mitogen-activated protein kinase kinase kinase kinase 4 | ENSG00000071054 | 604666 |